Pharmaceuticals

Changing the way therapies work, and the changing work of making therapies.

To bring the exciting science of cell and gene therapy manufacturing to life, creating smaller-scale filling solutions is imperative to the success of the ATMP industry. But before you begin scaling your operation, there are important questions to consider about fill-finish in ATMP.

Spray drying is a rapid, robust, reproducible, and scalable process.

Creating a roadmap to the digitalization of your next pharmaceutical facility.

New uses for oligonucleotides and increasing demand are driving oligo manufacturers to scale up to commercial production.

Keeping your plasma fractionation process and facility cold requires careful planning and design.

After decades of research, the oligonucleotide industry has reached a tipping point and is experiencing a huge surge of interest and momentum.

When it comes to highly complex plasma fractionation facilities, integrated project delivery is an optimal way to design and build.